Abbott (ABT) delivers beat-and-raise quarter despite a decline in Covid19-related sales

Go back to Abbott (ABT) delivers beat-and-raise quarter despite a decline in Covid19-related sales

Wolfe Research now neutral on Abbott (ABT) as short view becomes trickier

July 21, 2023 9:36 AM EDT

Abbott (NYSE: ABT) was lifted to Peer Perform from Underperform at Wolfe Research on Friday, with the firm removing its price target for the stock.

Analyst Mike Polark told investors in a note that "the edge has gone dull," and their... More